Proteon Therapeutics, Inc

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Roche Pushes Back Deadline A

The US FDA’s Center for Drug Evaluation and Research is coming off what in many lights could be the best year ever for new drugs – a record number of novel agents, reviewed in record low times, reflec

The latest breakthrough therapy designation (BTD) awards from FDA illustrate the expedited review program's appeal for sponsors who are entering Phase III in areas where there is little relevant prece

The table records clinical developments using data from Informa Pharma Intelligence’s Biomedtracker. It lists drugs for which an important event was recorded between Dec. 9 and Dec. 15, 2016, divided